Anthony Tang, ACC 2021: Findings from the RAFT-AF Trial

It was a great pleasure to meet with Anthony Tang to discuss the RAFT-AF trial results investigating the safety and efficacy of catheter ablation-based rhythm control compared with rate control for the treatment of patients with atrial fibrillation and heart failure, presented at ACC 2021. Abstract Title: A Randomized Ablation-based atrial Fibrillation rhythm control versus […]

Sanjiv Narayan, EHRA 2021 – AI and ML Models in Arrhythmias and Cardiac Electrophysiology

It was a pleasure to talk to Dr Sanjiv Narayan (Stanford University, Stanford, CA, USA) around the implementation of artificial intelligence and machine learning models in the field of arrhythmias and cardiac electrophysiology. Questions What are the major challenges in implementing artificial intelligence (AI) and machine learning (ML) models in the field of arrhythmias and […]

Federico Asch, ACC 2021 – Findings from the WASE COVID study

Federico Asch (MedStar Health Research Institute, Columbia, MD, USA) discusses the findings of the WASE COVID study, presented at ACC 2021. The study compared AI software-based echocardiography analysis with manual expert analysis to predict mortality based on longitudinal strain and LVEF. Abstract title: Human vs Machine Learning-based Echocardiography Analysis as Predictor of Outcomes in Acute […]

William Schulyer-Jones, ACC 2021 – Findings from the ADAPTIVE study

We were delighted to speak with Dr William Schulyer-Jones (Associate Professor of Medicine, Duke University School of Medicine, Durham, NC, USA) about the findings of the ADAPTABLE STUDY, a large randomized study assessing the benefits and long-term effectiveness of aspirin dosage (81 mg vs. 325mg) for patients with cardiovascular disease. Abstract title: Aspirin Dosing: A […]

Sodium–glucose Cotransporter 2 Inhibitors’ Rise to the Backbone of Heart Failure Management: A Clinical Review

Heart International. 15(1):Online ahead of journal publication

Heart failure (HF) is an increasingly prevalent clinical syndrome resulting from a variety of disease processes impeding the heart’s ability to effectively circulate blood. With advances in care and a steadily growing and aging population, HF management is becoming a foremost priority in developed nations like the USA, where HF is expected to affect more […]

Ambulatory Management of Worsening Heart Failure: Current Strategies and Future Directions

Heart International. 2021;15(1):Online ahead of journal publication

Heart failure (HF) is a highly prevalent and morbid disease in the USA, imposing a significant burden on patients, hospitals and the health system. The prevalence of HF continues to increase, with over 650,000 new HF cases diagnosed annually.1 There are over 6.2 million people with HF in the USA,2 with an expected increase to 8 million […]

Rhythm Disorders in Endocrinology

European Journal of Arrhythmia & Electrophysiology. 2021;7(1):Online ahead of journal publication

Several closely regulated ion channels are involved in the various phases of the myocardial action potential (phases 0–4) (Figure 1).1 In the absence of neuroendocrine and other regulatory signals, the pacing rate of the sinoatrial node is 100 beats per minute (bpm). However, heart rate is not fixed, and varies along with cardiac output in order […]

Supraventricular Tachycardia: Electrocardiogram Diagnosis and Clinical Management for the Non-electrophysiologist

European Journal of Arrhythmia & Electrophysiology. 2021;7(1):Online ahead of journal publication.

Supraventricular tachycardia (SVT) occurs with a prevalence of 2–3/1,000 in the general population and is characterised by atrial rates >100 beats per minute (bpm) at rest. Per definition, SVT originates in the atria or atrioventricular (AV) node tissue above the His bundle.1,2 Diagnosis and clinical management of SVT have been the focus of recent European Society […]